CoChat

A Blueprint to Advance Colorectal Cancer Immunotherapies

Le, Dung T., Hubbard-Lucey, Vanessa M., Morse, Michael A., Heery, Christopher R., Dwyer, Andrea, Marsilje, Thomas H., Brodsky, Arthur N., Chan, Emily, Deming, Dustin A., Diaz, Luis A., Fridman, Wolf H., Goldberg, Richard M., Hamilton, Stanley R., Housseau, Franck, Jaffee, Elizabeth M., Kang, S. Peter, Krishnamurthi, Smitha S., Lieu, Christopher H., Messersmith, Wells, Sears, Cynthia L., Segal, Neil H., Yang, Arvin, Moss, Rebecca A., Cha, Edward, O'Donnell-Tormey, Jill, Roach, Nancy, Davis, Anjelica Q., McAbee, Keavy, Worrall, Sharyn, Benson, Al B. · 2017 · Cancer Immunology Research
Cited by 69

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

Immunotherapy is rapidly becoming a standard of care for many cancers. However, colorectal cancer had been generally resistant to immunotherapy, despite features in common with sensitive tumors. Observations of substantial clinical activity for checkpoint blockade in colorectal cancers with defective mismatch repair (microsatellite instability–high tumors) have reignited interest in the search for immunotherapies that could be extended to the larger microsatellite stable (MSS) population. The Cancer Research Institute and Fight Colorectal Cancer convened a group of scientists, clinicians, advocates, and industry experts in colorectal cancer and immunotherapy to compile ongoing research efforts, identify gaps in translational and clinical research, and provide a blueprint to advance immunotherapy. We identified lack of a T-cell inflamed phenotype (due to inadequate T-cell infiltration, inadequate T-cell activation, or T-cell suppression) as a broad potential explanation for failure of checkpoint blockade in MSS. The specific cellular and molecular underpinnings for these various mechanisms are unclear. Whether biomarkers with prognostic value, such as the immunoscores and IFN signatures, would also predict benefit for immunotherapies in MSS colon cancer is unknown, but if so, these and other biomarkers for measuring the potential for an immune response in patients with colorectal cancer will need to be incorporated into clinical guidelines. We have proposed a framework for research to identify immunologic factors that may be modulated to improve immunotherapy for colorectal cancer patients, with the goal that the biomarkers and treatment strategies identified will become part of the routine management of colorectal cancer. Cancer Immunol Res; 5(11); 942–9. ©2017 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/2326-6066.cir-17-0375

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Cited by

See all 69

Metadata

Authors
Le, D. T., Hubbard-Lucey, V. M., Morse, M. A., Heery, C. R., Dwyer, A., Marsilje, T. H., Brodsky, A. N., Chan, E., Deming, D. A., Diaz, L. A., Fridman, W. H., Goldberg, R. M., Hamilton, S. R., Housseau, F., Jaffee, E. M., Kang, S. P., Krishnamurthi, S. S., Lieu, C. H., Messersmith, W., Sears, C. L., Segal, N. H., Yang, A., Moss, R. A., Cha, E., O'Donnell-Tormey, J., Roach, N., Davis, A. Q., McAbee, K., Worrall, S., & Benson, A. B.
Venue
Cancer Immunology Research
Published
2017-10-31
Volume
5
Issue
11
Pages
942-949
ISSN
  • 2326-6066 (ISSN-L)
  • 2326-6074
OpenAlex
W2765150551
Cited by
69
References
23
FWCI
3.88
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Blueprint to Advance Colorectal Cancer Immunotherapies. https://app.cochat.ai/papers/10.1158/2326-6066.cir-17-0375
The paper
Le, D. T., Hubbard-Lucey, V. M., Morse, M. A., Heery, C. R., Dwyer, A., Marsilje, T. H., Brodsky, A. N., Chan, E., Deming, D. A., Diaz, L. A., Fridman, W. H., Goldberg, R. M., Hamilton, S. R., Housseau, F., Jaffee, E. M., Kang, S. P., Krishnamurthi, S. S., Lieu, C. H., Messersmith, W., . . . Benson, A. B. (2017). A Blueprint to Advance Colorectal Cancer Immunotherapies. Cancer Immunology Research. https://doi.org/10.1158/2326-6066.cir-17-0375

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.